The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
Winter, W. E., Maxwell, G. L., Tian, C., Carlson, J. W., Ozols, R. F., Rose, P. G., Markman, M., Armstrong, D. K., Muggia, F., & McGuire, W. P. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.2517 · Cited by 845
Sugiyama, T., Kamura, T., Kigawa, J., Terakawa, N., Kikuchi, Y., Kita, T., Suzuki, M., Sato, I., & Taguchi, K. (2000) · Cancer · doi:10.1002/1097-0142(20000601)88:11<2584::aid-cncr22>3.0.co;2-5 · Cited by 795
[Prognostic factors in patients with stage I epithelial ovarian cancer].
Wen, H. W., & Liu, S. W. (1994) · PubMed · Cited by 353
Goff, B. A., Sainz de la Cuesta, R., Muntz, H. G., Fleischhacker, D., Ek, M., Rice, L. W., Nikrui, N., Tamimi, H. K., Cain, J. M., Greer, B. E., et al. (1996) · Gynecologic Oncology · doi:10.1006/gyno.1996.0065 · Cited by 352
Prognostic factors in patients with stage I epithelial ovarian cancer.
Dembo, A. J., Davy, M., Stenwig, A. E., et al. (1990) · PubMed · Cited by 291
Studying Radiation Therapy Using SEER-Medicare-Linked Data
Virnig, B. A., Warren, J. L., Cooper, G. S., Klabunde, C. N., Schussler, N., & Freeman, J. (2002) · Medical Care · doi:10.1097/00005650-200208001-00007 · Cited by 286
Pectasides, D., Fountzilas, G., Aravantinos, G., Kalofonos, H. P., Efstathiou, E., Salamalekis, E., Farmakis, D., Skarlos, D., Briasoulis, E., Economopoulos, T., et al. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.12.056 · Cited by 215
Ovarian clear cell adenocarcinoma
Kennedy, A. W., Biscotti, C. V., Hart, W. R., & Webster, K. D. (1989) · Gynecologic Oncology · doi:10.1016/0090-8258(89)90637-9 · Cited by 178
Clear cell adenocarcinoma of the ovary: A clinical analysis and comparison with serous carcinoma
Jenison, E. L., Montag, A. G., Griffiths, C. T., Welch, W. R., Lavin, P. T., Greer, J., & Knapp, R. C. (1989) · Gynecologic Oncology · doi:10.1016/0090-8258(89)90852-4 · Cited by 164
Cited by
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
Peres, L. C., Cushing-Haugen, K. L., Köbel, M., Harris, H. R., Berchuck, A., Rossing, M. A., Schildkraut, J. M., & Doherty, J. A. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy071 · Cited by 554
Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma
Kuo, K.-T., Mao, T.-L., Jones, S., Veras, E., Ayhan, A., Wang, T.-L., Glas, R., Slamon, D., Velculescu, V. E., Kuman, R. J., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.081000 · Cited by 485
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer
Chan, J. K., Brady, M. F., Penson, R. T., Huang, H., Birrer, M. J., Walker, J. L., DiSilvestro, P. A., Rubin, S. C., Martin, L. P., Davidson, S. A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505067 · Cited by 367
Self-citationYamamoto, S., Tsuda, H., Takano, M., Iwaya, K., Tamai, S., & Matsubara, O. (2011) · The Journal of Pathology · doi:10.1002/path.2940 · Cited by 152
Hoskins, P. J., Le, N., Gilks, B., Tinker, A., Santos, J., Wong, F., & Swenerton, K. D. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.1646 · Cited by 117
Metadata
- Authors
- Chan, J. K., Teoh, D., Hu, J. M., Shin, J. Y., Osann, K., & Kapp, D. S.
- Venue
- Gynecologic Oncology
- Publisher
- Elsevier BV
- Published
- 2008-06
- Volume
- 109
- Issue
- 3
- Pages
- 370-376
- ISSN
- 0090-8258 (ISSN-L)
- OpenAlex
- W1979879868
- Cited by
- 450
- References
- 20
- FWCI
- 17.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. https://app.cochat.ai/papers/10.1016/j.ygyno.2008.02.006
- The paper
- Chan, J. K., Teoh, D., Hu, J. M., Shin, J. Y., Osann, K., & Kapp, D. S. (2008). Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2008.02.006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.